Does Vestibular Rehabilitation Significantly Improve the Level of Vestibular Function Following Vestibular Neuritis?

Which Treatment is Most Effective When Treating Vestibular Neuritis: Corticosteroid Treatment Alone or Combined Corticosteroid Treatment and Vestibular Rehabilitation?

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03821155

Enrollment

Registered

2019-01-29

Start date

2019-02-01

Completion date

2022-01-01

Last updated

2022-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vestibular Neuritis

Keywords

Vestibular Neuritis, SHIMP (suppressing head impulse paradigm), SVV (subjective visual vertical), Vestibular rehabilitation, Prednisolone, v-HIT (video head impulse test), Vestibular Neuronitis

Brief summary

To investigate which treatment option (corticosteroid treatment alone or combined corticosteroid treatment and vestibular rehabilitation) is the most effective in patients diagnosed with vestibular neuritis.

Detailed description

Patients diagnosed with vestibular neuritis will we consider for enrollment. Each patient will undergo randomization for a specific treatment.

Interventions

OTHERVestibular rehabilitation

Specialized physical therapy aimed at restoring balance

DRUGCorticosteroid

Prednisolone

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Intervention model description

Patients randomized to two different treatments: 1. corticosteroid treatment (prednisolone) 2. combined corticosteroid treatment (prednisolone) and vestibular rehabilitation

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Age above 18 years of age 2. Medical history compatible with vestibular neuritis 3. Verification of vestibular neuritis with positive romberg test, pathological v-HIT and horizontal nystagmus with a rotatory component.

Exclusion criteria

1. Former medical history with vestibular dysfunction 2. Medical history or objective signs of cochlear dysfunction before, during or after onset of vestibular neuritis 3. Onset of symptoms 14 days before recruitment to the study 4. Focal neurological symptoms/signs 5. Contraindication to prednisolone treatment 6. Problem with participating in vestibular rehabilitation due to muscular-skeletal disease ect.

Design outcomes

Primary

Measure	Time frame	Description
Suppressing head impulse paradigm (SHIMP)	6 month	SHIMP equipment will objectively quantify change of vestibular function.
Subjective visual vertical (SVV)	6 month	SVV test will objectively quantify the experienced spatial orientation as an indicator of visual and vestibular otolithic function
Video head impulse test (v-HIT)	6 month	v-HIT equipment will objectively quantify change of vestibular function.
Dizziness handicap inventory (DHI) questionnaire	6 month	Fulfillment of the questionnaire Dizziness Handicap Inventory (DHI) will quantify the level of experienced vertigo.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026